Prevalence of HTLV‐I in arctic regions
Marjorie Robert‐Guroff(National Cancer Institute), Robert C. Gallo(University of South Florida), G. Beckman(Umeå University), Jeffrey W. Clark(Massachusetts General Hospital), Anne P. Lanier(Indian Health Service), Mads Melbye(University of Copenhagen), William A. Blattner(Unknown), Peter Ebbesen(National Cancer Institute)
Cited by 30
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k